University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Hand Osteoarthritis: Investigating Pain Trajectories and Association With Biomarkers Including Estrogen Cohort

Active, not recruiting

Conditions: Hand Osteoarthritis

First Posted Date: 2021-11-03

Last Posted Date: 2022-12-06

Lead Sponsor: University of Oxford

Target Recruit Count: 120

Registration Number: NCT05105854

Locations: 🇬🇧
Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧
Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Angelman Syndrome Natural History Study-FAST UK

Recruiting

Conditions: Angelman Syndrome

Interventions: Other: Natural History Study

First Posted Date: 2021-10-29

Last Posted Date: 2024-02-28

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT05100810

Locations: 🇬🇧
University of Oxford, Oxford, Oxon, United Kingdom

Price Promotions on Purchases of Snacks

Not Applicable

Completed

Conditions: Healthy Diet

Interventions: Behavioral: Intervention to remove price promotions on unhealthy foods when online shopping

First Posted Date: 2021-10-28

Last Posted Date: 2022-02-17

Lead Sponsor: University of Oxford

Target Recruit Count: 512

Registration Number: NCT05098223

Locations: 🇬🇧
Nuffield Dept of Primary Care Health Sciences, Oxford, Oxfordshire, United Kingdom

A Study of a New Vaccine Against Two Types of Ebola

Phase 1

Completed

Conditions: Ebola

Interventions: Biological: ChAdOx1 biEBOV

First Posted Date: 2021-10-15

Last Posted Date: 2023-04-19

Lead Sponsor: University of Oxford

Target Recruit Count: 26

Registration Number: NCT05079750

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

Monitoring Pregnant Women for Antimalarial Drug Resistance

Completed

Conditions: Malaria

Interventions: Other: Malaria screening

First Posted Date: 2021-10-11

Last Posted Date: 2023-12-06

Lead Sponsor: University of Oxford

Target Recruit Count: 6833

Registration Number: NCT05072613

Locations: 🇨🇩
Kinshasa Medical Oxford Research Unit, Kinsasa, Congo, The Democratic Republic of the

PLH for Teens - Hybrid Delivery

Not Applicable

Completed

Conditions: Child Maltreatment
Positive Parenting

First Posted Date: 2021-10-08

Last Posted Date: 2024-05-08

Lead Sponsor: University of Oxford

Target Recruit Count: 1128

Registration Number: NCT05071924

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes

Not Applicable

Recruiting

Conditions: Plasmodium Vivax Infection

Interventions: Biological: An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum

First Posted Date: 2021-10-07

Last Posted Date: 2024-06-26

Lead Sponsor: University of Oxford

Target Recruit Count: 48

Registration Number: NCT05071079

Locations: 🇹🇭
Faculty of Tropical Medicine, Bangkok, Thailand

Village Malaria Worker Expansion

Recruiting

Conditions: Febrile Illness

First Posted Date: 2021-09-16

Last Posted Date: 2023-04-07

Lead Sponsor: University of Oxford

Target Recruit Count: 7000

Registration Number: NCT05045547

Locations: 🇰🇭
Action for Health and Development, Battambang, Cambodia

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Phase 2

Recruiting

Conditions: COVID-19

Interventions: Drug: Nirmatrelvir/ritonavir (e.g. PAXLOVID™)
Drug: Nitazoxanide
Drug: Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™)
Drug: Hydroxychloroquine
Other: No treatment
Drug: Monoclonal antibodies
Drug: Fluoxetine
Drug: Molnupiravir
Drug: Sotrovimab
Drug: Ensitrelvir
Drug: Favipiravir
Drug: Ivermectin
Drug: Remdesivir
Drug: Atilotrelvir/ritonavir
Drug: Metformin
Drug: Nirmatrelvir/ritonavir
Drug: Nirmatrelvir

First Posted Date: 2021-09-13

Last Posted Date: 2024-10-28

Lead Sponsor: University of Oxford

Target Recruit Count: 3800

Registration Number: NCT05041907

Locations: 🇳🇵
Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, Nepal
🇧🇷
Universidade Federal de Minas Gerais, Minas Gerais, Brazil
🇱🇦
Laos-Oxford-Mahosot Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic

and more 4 locations

Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit

Completed

Conditions: Critical Illness
Covid19
Intensive Care Unit Delirium
Sedation Complication
Analgesia

Interventions: Other: No intervention

First Posted Date: 2021-08-30

Last Posted Date: 2023-06-06

Lead Sponsor: University of Oxford

Target Recruit Count: 3421

Registration Number: NCT05027217

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy